Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)

Hyundai Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,293,114	476,821	561,851	1,038,982	1,087,244	976,101
Market Cap Growth	160.94%	-15.13%	-45.92%	-4.44%	11.39%	-6.92%
Enterprise Value	1,270,821	447,462	579,143	1,031,571	1,069,527	969,321
Last Close Price	13400.00	4965.00	7055.00	12295.97	12908.41	11895.53
PS Ratio	367.64	135.56	37.33	109.58	138.48	105.62
PB Ratio	11.68	4.31	14.25	22.95	18.67	15.85
P/TBV Ratio	22.08	8.14	89.63	73.68	43.38	34.98
P/FCF Ratio	-	-	269.15	-	-	-
P/OCF Ratio	-	-	248.93	-	-	-
EV/Sales Ratio	-	127.22	38.48	108.80	136.22	104.89
EV/EBITDA Ratio	-	-	394.62	-	-	-
EV/EBIT Ratio	-	-	694.59	-	-	-
EV/FCF Ratio	-69.66	-	277.44	-	-	-
Debt / Equity Ratio	0.16	0.16	0.67	0.12	0.11	0.25
Debt / EBITDA Ratio	-	-	18.12	-	-	-
Debt / FCF Ratio	-	-	12.74	-	-	-
Net Debt / Equity Ratio	-0.20	-0.20	0.58	-0.14	-0.21	-0.11
Net Debt / EBITDA Ratio	1.32	1.32	15.63	0.75	0.51	1.02
Net Debt / FCF Ratio	1.22	1.22	10.99	0.96	0.69	1.57
Asset Turnover	0.04	0.04	0.25	0.16	0.11	0.11
Inventory Turnover	3.18	3.18	1.78	1.62	1.63	1.59
Quick Ratio	2.18	2.18	0.14	1.77	2.23	1.73
Current Ratio	2.25	2.25	0.25	2.18	2.67	2.02
Return on Equity (ROE)	-29.45%	-29.45%	-16.26%	-28.02%	-26.39%	-35.21%
Return on Assets (ROA)	-11.44%	-11.44%	0.86%	-10.20%	-22.24%	-6.66%
Return on Invested Capital (ROIC)	-21.45%	-24.09%	1.65%	-23.13%	-52.30%	-14.85%
Return on Capital Employed (ROCE)	-16.30%	-16.30%	2.10%	-21.40%	-45.10%	-14.70%
Earnings Yield	-1.71%	-4.64%	-1.23%	-1.40%	-1.45%	-2.05%
FCF Yield	-1.41%	-3.83%	0.37%	-0.63%	-1.66%	-0.44%
Buyback Yield / Dilution	-721.14%	-721.14%	-16030.92%	-1.04%	-6.64%	-2.79%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.